Sundas Fayyaz
Overview
Explore the profile of Sundas Fayyaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mobeen I, Romero M, Yulaevna I, Attar R, Jabeen S, Fayyaz S
Cell Mol Biol (Noisy-le-grand)
. 2022 Jul;
67(6):318-329.
PMID: 35818180
On the translational front, integrative genomic approaches have spurred the identification of diverse mechanisms of drug resistance, tumor heterogeneity, metastasis and emerging preclinical targets. Recent breakthroughs in oncogenic cell signaling...
2.
Farooqi A, Fayyaz S, Poltronieri P, Calin G, Mallardo M
Semin Cancer Biol
. 2020 Aug;
83:197-207.
PMID: 32738290
Data obtained from cutting-edge research have shown that deregulated epigenetic marks are critical hallmarks of cancer. Rapidly emerging scientific evidence has helped in developing a proper understanding of the mechanisms...
3.
Fayyaz S, Attar R, Xu B, Sabitaliyevich U, Adylova A, Fares M, et al.
Anticancer Agents Med Chem
. 2020 Mar;
20(15):1780-1786.
PMID: 32160854
Blueberries belong to the genus Vaccinium of the family Ericaceae. Rapidly accumulating experimentally verified data is uncovering the tremendous pharmacological properties of biologically active constituents of blueberries against different diseases....
4.
Fayyaz S, Qureshi M, Alhewairini S, Avnioglu S, Attar R, Sabitaliyevich U, et al.
Cell Mol Biol (Noisy-le-grand)
. 2019 Dec;
65(7):15-20.
PMID: 31880533
Ampelopsin or Dihydromyricetin is gradually emerging as a high-quality natural product because of its ability to modulate wide-ranging signaling pathways. Ampelopsin (Dihydromyricetin) has been reported to effectively modulate growth factor...
5.
Farooqi A, Qureshi M, Attar R, Alhewairini S, Fayyaz S, Sabitaliyevich U, et al.
Cell Mol Biol (Noisy-le-grand)
. 2019 Sep;
65(6):1-5.
PMID: 31472055
Central dogma of molecular biology, a term coined by Francis Crick in 1958 was considered to be the cornerstone of molecular biology unless molecular biologists challenged the idea after ground-breaking...
6.
Farooqi A, Fuentes-Mattei E, Fayyaz S, Raj P, Goblirsch M, Poltronieri P, et al.
Semin Cancer Biol
. 2019 Feb;
58:47-55.
PMID: 30742906
Epigenetic abnormalities and aberrant expression of non-coding RNAs are two emerging features of cancer cells, both of which are responsible for deregulated gene expression. In this review, we describe the...
7.
Fayyaz S, Javed Z, Attar R, Farooqi A, Yaylim I, Ahmad A
Semin Cancer Biol
. 2019 Feb;
58:56-64.
PMID: 30716480
Large-scale sequencing methodologies have helped us identify numerous genomic alterations and we have started to scratch the surface of many new targets for treatment of cancer and the associated predictive...
8.
Farooqi A, Attar R, Qureshi M, Fayyaz S, Sohail M, Sabitaliyevich U, et al.
Cell Mol Biol (Noisy-le-grand)
. 2019 Jan;
64(15):1-6.
PMID: 30672446
Based on the exciting insights gleaned from decades of ground-breaking research, it has become evident that deregulated signaling pathways play instrumental role in cancer development and progression. Interestingly discovery of...
9.
Tang J, Ou-Yang F, Hou M, Huang H, Wang H, Li K, et al.
Semin Cancer Biol
. 2018 Aug;
58:109-117.
PMID: 30149066
To achieve preferential effects against cancer cells but less damage to normal cells is one of the main challenges of cancer research. In this review, we explore the roles and...
10.
TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy
Farooqi A, Shu C, Huang H, Wang H, Chang Y, Fayyaz S, et al.
Int J Mol Sci
. 2017 Jul;
18(7).
PMID: 28708091
Clinical studies and cancer cell models emphasize the importance of targeting therapies for oral cancer. The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is highly expressed in cancer, and is a...